Our results have confirmed increased expression of VEGFR1 in metastatic RCC, implicating up regulation of angiogenesis and lymphangiogenesis, and supporting the use of VEGF targeted therapies in metastatic disease. The gene discussed is VEGFA; the disease is renal cell carcinoma.